USS Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
16,867
+103
| +0.6% | +$22.5K | 0.02% | 411 |
|
|
2025
Q1 | $3.75M | Hold |
16,764
| – | – | 0.03% | 385 |
|
|
2024
Q4 | $5.49M | Sell |
16,764
-4,527
| -21% | -$1.48M | 0.04% | 351 |
|
|
2024
Q3 | $6.39M | Buy |
21,291
+880
| +4% | +$264K | 0.05% | 355 |
|
|
2024
Q2 | $6.72M | Buy |
20,411
+753
| +4% | +$248K | 0.05% | 294 |
|
|
2024
Q1 | $7.77M | Sell |
19,658
-2,016
| -9% | -$797K | 0.06% | 258 |
|
|
2023
Q4 | $7.64M | Buy |
21,674
+37
| +0.2% | +$13K | 0.07% | 246 |
|
|
2023
Q3 | $8.13M | Buy |
+21,637
| New | +$8.13M | 0.09% | 229 |
|
|
2022
Q3 | – | Sell |
-5,480
| Closed | -$1.66M | – | 701 |
|
|
2022
Q2 | $1.66M | Sell |
5,480
-1,135
| -17% | -$344K | 0.02% | 564 |
|
|
2022
Q1 | $2.72M | Sell |
6,615
-9,751
| -60% | -$4.01M | 0.02% | 538 |
|
|
2021
Q4 | $7.68M | Hold |
16,366
| – | – | 0.06% | 338 |
|
|
2021
Q3 | $6.95M | Sell |
16,366
-303,642
| -95% | -$129M | 0.06% | 337 |
|
|
2021
Q2 | $115M | Hold |
320,008
| – | – | 0.91% | 28 |
|
|
2021
Q1 | $90.3M | Hold |
320,008
| – | – | 0.78% | 31 |
|
|
2020
Q4 | $90.6M | Hold |
320,008
| – | – | 0.82% | 31 |
|
|
2020
Q3 | $87.9M | Hold |
320,008
| – | – | 0.85% | 26 |
|
|
2020
Q2 | $72.7M | Sell |
320,008
-105,540
| -25% | -$24M | 0.76% | 33 |
|
|
2020
Q1 | $65M | Sell |
425,548
-54,550
| -11% | -$8.33M | 0.88% | 38 |
|
|
2019
Q4 | $72.1M | Sell |
480,098
-53,422
| -10% | -$8.03M | 0.7% | 49 |
|
|
2019
Q3 | $75.6M | Sell |
533,520
-553,558
| -51% | -$78.5M | 0.78% | 41 |
|
|
2019
Q2 | $136M | Hold |
1,087,078
| – | – | 1.4% | 26 |
|
|
2019
Q1 | $120M | Hold |
1,087,078
| – | – | 1.35% | 35 |
|
|
2018
Q4 | $107M | Hold |
1,087,078
| – | – | 1.31% | 37 |
|
|
2018
Q3 | $134M | Hold |
1,087,078
| – | – | 1.35% | 31 |
|
|
2018
Q2 | $108M | Buy |
1,087,078
+214,707
| +25% | +$21.3M | 1.18% | 36 |
|
|
2018
Q1 | $77M | Buy |
+872,371
| New | +$77M | 0.85% | 39 |
|